一次性十二指腸鏡市場機會、成長動力、產業趨勢分析及 2025 - 2034 年預測

2024年，全球一次性十二指腸鏡市場規模達4,020萬美元，預計複合年成長率為10.1%，到2034年將達到1.034億美元。這一成長主要源於感染控制需求的不斷成長、設備設計的技術進步以及胃腸道疾病的日益增加。醫療保健機構正轉向使用一次性十二指腸鏡來提高病患安全性並降低交叉污染的風險，而交叉污染問題在臨床環境中日益受到關注。

隨著越來越多的醫院和診所採用先進的內視鏡解決方案，這些設備的使用頻率也越來越高，尤其是考慮到其一次性使用的特點，無需複雜的消毒程序，降低了感染風險。成像相容性的提升、更優的材料選擇以及以患者為中心的設計也加速了這些一次性工具的普及。隨著醫療保健產業越來越重視減少醫院內感染，向一次性解決方案的過渡正成為當務之急。

持續的產品創新進一步推動了市場的成長，旨在提高診斷準確性和臨床療效。一次性十二指腸鏡專為十二指腸內視鏡手術而設計，比可重複使用型產品更安全。這些設備使用後即可丟棄，避免了任何與重複處理相關的問題。近期的設計改進使其能夠更輕鬆地與現有成像平台整合，在手術過程中提供更清晰、即時的視覺效果，從而實現更精準的診斷。醫療保健專業人員更青睞一次性十二指腸鏡，因為它們降低了手術複雜性，並消除了重複使用型內視鏡重複處理帶來的污染風險。更高的可靠性和易用性使這些設備成為內視鏡手術不可或缺的一部分。

2024年，影片十二指腸鏡市場規模達3,570萬美元。這類鏡組因其與院內成像系統配合使用時可提供高清影像而廣受歡迎。其實即時成像功能使臨床醫生能夠更清晰地發現胃腸道中即使是微小的異常。除了提高診斷準確性外，這些鏡組還省去了清潔和消毒環節，從而降低了感染的可能性，而清潔和消毒環節一直以來都存在污染風險。隨著醫療保健系統採用包括高清和超高清格式在內的先進視訊技術，一次性視訊十二指腸鏡的需求預計將進一步成長。它們能夠提供無菌、可靠的診斷工具，是安全內視鏡檢查程序的關鍵。

直銷業務在2024年貢獻了2,600萬美元，預計到2034年將以10.5%的複合年成長率成長。直銷管道使製造商能夠與醫療保健專業人士建立更緊密的關係，提供客製化支援、即時回饋和客製化培訓。這種協作方式能夠更好地理解最終用戶的需求，並加快技術支援和產品改進的交付。對於十二指腸鏡等醫療器材而言，直接互動可以確保顧客服務的精準性，並增強品牌忠誠度。它還能使公司獲得即時的臨床回饋，調整產品策略，並根據市場需求最佳化未來的產品設計。

美國一次性十二指腸鏡市場規模在2024年達到1,540萬美元，預計2025年至2034年期間的複合年成長率將達到9.3%。由於良好的報銷趨勢以及對降低感染風險的日益重視，該市場需求正在不斷成長。該地區的醫療保健提供者正在從可重複使用的器械轉向支援感染控制工作的一次性器械。膽管阻塞、胰臟炎和胃腸道癌症等胃腸道疾病負擔日益加重，對安全有效的診斷工具的需求也日益旺盛。加上政策支援和設備技術的進步，美國將繼續推動整體市場擴張。

引領全球一次性十二指腸鏡市場的知名公司包括賓得醫療、富士膠片、波士頓科學、安布、史托斯、奧林巴斯和奧華。這些公司正積極推行策略性舉措，以鞏固其在不斷成長的市場中的地位。他們專注於持續的產品升級，整合高清視訊技術，並推出更符合人體工學且更易於使用的型號。許多公司正在擴大直銷隊伍，以增強客戶參與度和售後服務。此外，與醫療機構的合作研發和策略合作夥伴關係有助於這些公司始終領先於技術需求和臨床需求。簡化製造流程、獲得監管部門批准以及擴大生產能力是他們搶佔更大市場佔有率的策略。

目錄

第1章：方法論與範圍

第2章：執行摘要

第3章：行業洞察

• 產業生態系統分析
• 產業衝擊力
  • 成長動力
    • 胃腸道疾病盛行率不斷上升
    • 技術進步
    • 提高患者和醫療保健專業人員的意識
  • 產業陷阱與挑戰
    • 與設備相關的高成本
• 成長潛力分析
• 監管格局
  • 美國
  • 歐洲
• 技術格局
• 報銷場景
• 波特的分析
• PESTEL分析
• 差距分析
• 價值鏈分析
• 專利分析

第4章：競爭格局

• 介紹
• 公司矩陣分析
• 公司市佔率分析
• 主要市場參與者的競爭分析
• 競爭定位矩陣
• 策略儀表板

第5章：市場估計與預測：按類別，2021 - 2034 年

• 主要趨勢
• 影片十二指腸鏡
• 光纖十二指腸鏡

第6章：市場估計與預測：按銷售管道，2021 - 2034 年

• 主要趨勢
• 直銷
• 間接銷售

第7章：市場估計與預測：依最終用途，2021 - 2034 年

• 主要趨勢
• 醫院
• 門診手術中心
• 其他最終用戶

第8章：市場估計與預測：按地區，2021 - 2034 年

• 主要趨勢
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 荷蘭
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 韓國
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中東和非洲
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第9章：公司簡介

• Ambu
• AOHUA
• Boston Scientific
• FUJIFILM
• OLYMPUS
• PENTAX MEDICAL
• STORZ

The Global Single-Use Duodenoscope Market was valued at USD 40.2 million in 2024 and is estimated to grow at a CAGR of 10.1% to reach USD 103.4 million by 2034. The growth is driven by the rising demand for infection control, technological improvements in device design, and the increasing prevalence of gastrointestinal conditions. Healthcare providers are turning to disposable duodenoscopes to improve patient safety and reduce the risk of cross-contamination, a concern that continues to gain traction across clinical settings.

As more hospitals and clinics adopt advanced endoscopic solutions, these devices are being used more frequently, especially in light of their one-time use format, which eliminates the need for complex sterilization procedures and reduces infection risks. Improvements in imaging compatibility, better material choices, and patient-centric designs are also accelerating the adoption of these disposable tools. With the healthcare sector increasingly focused on reducing hospital-acquired infections, the transition to single-use solutions is becoming a top priority.

The market's growth is further supported by continuous product innovation to improve diagnostic accuracy and clinical outcomes. Single-use duodenoscopes are specifically engineered for endoscopic procedures in the duodenum, offering a safer alternative to reusable models. Once used, these devices are discarded, eliminating any reprocessing-related issues. Recent enhancements in design have enabled easier integration with existing imaging platforms, delivering sharper, real-time visuals during procedures and resulting in more precise diagnoses. Healthcare professionals prefer disposable models as they reduce procedural complexity and eliminate contamination risks associated with reprocessing reusable scopes. Greater reliability and ease of use make these devices an integral part of endoscopic procedures.

The video duodenoscope segment generated USD 35.7 million in 2024. These scopes have gained wide acceptance because they deliver high-definition visuals when paired with in-house imaging systems. Their real-time imaging capabilities allow clinicians to spot even minor anomalies in the gastrointestinal tract with enhanced clarity. In addition to improving diagnostic accuracy, these video scopes reduce the likelihood of infection by eliminating the cleaning and disinfection process, which has historically posed contamination risks. As healthcare systems adopt advanced video technologies, including HD and UHD formats, the demand for disposable video duodenoscopes is projected to rise further. Their ability to provide a sterile, reliable diagnostic tool makes them essential for safe endoscopic procedures.

The direct sales segment contributed USD 26 million in 2024 and is anticipated to grow at a CAGR of 10.5% through 2034. The direct sales channel enables manufacturers to build closer relationships with healthcare professionals, offering tailored support, real-time feedback, and customized training. This collaborative approach ensures a better understanding of end-user requirements and accelerates the delivery of technical support and product improvements. For medical devices like duodenoscopes, direct engagement ensures precision in customer service and strengthens brand loyalty. It also allows companies to receive immediate clinical feedback, adapt product strategies, and optimize future product designs based on market needs.

United States Single-Use Duodenoscope Market reached USD 15.4 million in 2024 and is projected to grow at a CAGR of 9.3% between 2025 and 2034. The demand is rising due to favorable reimbursement trends and a growing emphasis on minimizing infection risks. Healthcare providers in the region are shifting away from reusable options toward disposable alternatives that support infection control efforts. The increasing burden of gastrointestinal diseases, including bile duct blockages, pancreatitis, and GI cancers, is creating a strong demand for safe and effective diagnostic tools. Coupled with policy support and advancements in device technology, the U.S. continues to contribute to overall market expansion.

Prominent companies leading the Global Single-Use Duodenoscope Market include PENTAX MEDICAL, FUJIFILM, Boston Scientific, Ambu, STORZ, OLYMPUS, and AOHUA. These companies are actively pursuing strategic moves to strengthen their position in the growing market. They focus on continuous product upgrades, integrating high-definition video technologies, and launching models with improved ergonomics and ease of use. Many are expanding their direct sales force to enhance customer engagement and post-sale service. In addition, collaborative R&D efforts and strategic partnerships with healthcare facilities help these players stay ahead of technological demands and clinical needs. Streamlining manufacturing processes, securing regulatory approvals, and scaling production capabilities form their strategy to capture greater market share.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing prevalence of gastrointestinal disorders
    • 3.2.1.2 Technological advancements
    • 3.2.1.3 Rising awareness among patients and healthcare professionals
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost associated with device
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 U.S.
  • 3.4.2 Europe
• 3.5 Technology landscape
• 3.6 Reimbursement scenario
• 3.7 Porter's analysis
• 3.8 PESTEL analysis
• 3.9 Gap analysis
• 3.10 Value chain analysis
• 3.11 Patent Analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Category, 2021 - 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Video duodenoscopes
• 5.3 Fiber optic duodenoscopes

Chapter 6 Market Estimates and Forecast, By Sales Channel, 2021 - 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Direct sales
• 6.3 In-direct sales

Chapter 7 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals
• 7.3 Ambulatory surgical centers
• 7.4 Other end users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE

Chapter 9 Company Profiles

• 9.1 Ambu
• 9.2 AOHUA
• 9.3 Boston Scientific
• 9.4 FUJIFILM
• 9.5 OLYMPUS
• 9.6 PENTAX MEDICAL
• 9.7 STORZ